SCHEMBL7975133

SCHEMBL7975133

Nc1ccc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA1 P30542 1/20 0.41
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
PI4KA P42356 1/20 0.39
PI4K2B Q8TCG2 1/20 0.39
PI4K2A Q9BTU6 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
HPGDS O60760 1/20 0.38
PNP P00491 2/20 0.38
GAA P10253 2/20 0.38
PARN O95453 1/20 0.38
CNOT7 Q9UIV1 1/20 0.38
MET P08581 1/20 0.38
TNF P01375 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7985515 0.99 ADORA2A (0.49) ADORA2ASMN1; SMN2ALDH1A1ADORA3ADORA1
SCHEMBL7975267 0.92 SMN1; SMN2 (0.46) ADORA2ASMN1; SMN2ALDH1A1ADORA3ADORA1
SCHEMBL7988558 0.91 SMN1; SMN2 (0.43) ADORA2ASMN1; SMN2ALDH1A1ADORA3ADORA1
SCHEMBL7984459 0.90 NR1H2 (0.43) ADORA2ASMN1; SMN2ALDH1A1ADORA3ADORA1
SCHEMBL7974507 0.89 MET (0.46) ADORA2ASMN1; SMN2ALDH1A1ADORA3HPGD
SCHEMBL7985060 0.88 ADORA2A (0.39) ADORA2ASMN1; SMN2HPGDMETCYP11B1
SCHEMBL7974441 0.88 GRK2 (0.43) ADORA2ASMN1; SMN2ALDH1A1ADORA3HPGD
SCHEMBL7984490 0.87 CNOT7 (0.41) ADORA2AALDH1A1ADORA3ADORA1HPGD
SCHEMBL7984659 0.87 ALDH1A1 (0.44) ADORA2ASMN1; SMN2ALDH1A1ADORA3ADORA1
SCHEMBL7985236 0.86 LMNA (0.44) ADORA2ASMN1; SMN2ALDH1A1ADORA1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed